Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03862677
Determining Prognostic Immune Markers in Patients With Ovarian Cancer
Sponsor: Leiden University Medical Center
View on ClinicalTrials.gov
Summary
The IMPRoVE study is a prospective, non-interventional, explorative cohort study to determine prognostic immune markers in patients with epithelial ovarian cancer, fallopian tube cancer, and primary peritoneal cancer (EOC).
Key Details
Gender
FEMALE
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2020-08-15
Completion Date
2027-01-31
Last Updated
2026-02-13
Healthy Volunteers
No
Conditions
Interventions
OTHER
No intervention
Observational study, no intervention
Locations (1)
Leiden University Medical Center
Leiden, Netherlands